Inhibition of CD44 expression in hepatocellular carcinoma cells enhances apoptosis, chemosensitivity, and reduces tumorigenesis and invasion

Targeting of CD44 eradicates human acute myeloid leukemic stem cells

Liqing Jin, Kristin J. Hope, Qiongli Zhai et al. · Nature Medicine · 2006 · 1.2K citations

Medicine, Hematology, Oncology +10

The CD44 Receptor Interacts with P-Glycoprotein to Promote Cell Migration and Invasion in Cancer

Karl E. Miletti-González, Shiling Chen, N. Muthukumaran et al. · Cancer Research · 2005 · 208 citations

Medicine, Cancer Biology, Oncology +16

Hyaluronan-CD44 Interaction with Leukemia-associated RhoGEF and Epidermal Growth Factor Receptor Promotes Rho/Ras Co-activation, Phospholipase Cϵ-Ca2+ Signaling, and Cytoskeleton Modification in Head and Neck Squamous Cell Carcinoma Cells

Lilly Bourguignon, Eli Gilad, Amy Brightman et al. · Journal of Biological Chemistry · 2006 · 207 citations · Full text

Life Sciences, Cancer Biology, Cell Biology +17

Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients

Tim F. Greten, F Papendorf, J. Bleck et al. · British Journal of Cancer · 2005 · 193 citations · Full text

Medicine, Oncology, Cancer Control +16

Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival

Kanenori Endo, Tadashi Terada · Journal of Hepatology · 2000 · 167 citations

Medicine, Oncology, Pathology +17